Press Releases :: BiomX, Inc. (PHGE)

Mar 26, 2020 6:30am EDT

BiomX Reports Full Year 2019 Financial Results and Provides Business Update

Mar 20, 2020 8:00am EDT

BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting

Feb 17, 2020 7:00am EST

BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference

Feb 03, 2020 6:00am EST

BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange

Dec 02, 2019 7:30am EST

BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin

Nov 12, 2019 7:30am EST

BiomX Presents Preclinical Results of its Phage Therapy Program Targeting Primary Sclerosing Cholangitis

Nov 04, 2019 5:38pm EST

BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director

Nov 04, 2019 7:30am EST

BiomX To Present at Plenary Session of the AASLD Liver Conference

Oct 15, 2019 7:30am EDT

BiomX Appoints Merav Bassan as Chief Development Officer

Sep 30, 2019 7:30am EDT

BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria

Previous
1…
4
5
6
7
8
9
10
11
12
13
Next

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com